Axel Schambach

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 319 publications

Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.

Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors.

Journal: Human gene therapy

Published: August 03, 2026

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Journal: Human gene therapy

Published: July 07, 2026

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Genomic profiling identifies actionable DNA-repair defects in a new cervical cancer model.

Journal: Scientific reports

Published: May 15, 2026

Sound effects: paradigm gene therapy approach installs hearing in children and adolescents born deaf.

Sound effects: paradigm gene therapy approach installs hearing in children and adolescents born deaf.

Journal: Signal transduction and targeted therapy

Published: April 24, 2026

Addressing the package: Cell-specific gene delivery using lentiviral vectors.

Addressing the package: Cell-specific gene delivery using lentiviral vectors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 19, 2026

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Journal: Frontiers in immunology

Published: March 18, 2026

SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential.

SAGA-Q: Gene Expression Differences Enable Detection of Retroviral Vectors with Mutagenic Potential.

Journal: Human gene therapy

Published: January 30, 2026

Integrated Multi-omics Analysis Uncovers Molecular Dysregulation in Glycosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells.

Integrated Multi-omics Analysis Uncovers Molecular Dysregulation in Glycosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells.

Journal: Molecular & cellular proteomics : MCP

Published: January 26, 2026

Septin7 is essential in early hematopoiesis, but redundant at later stages.

Septin7 is essential in early hematopoiesis, but redundant at later stages.

Journal: Life science alliance

Published: January 26, 2026

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Journal: Obstetrical & gynecological survey

Published: December 30, 2025

Ex vivo long-term expansion of human hematopoietic stem and progenitor cells as a tool for modeling vector integration sites and clonality.

Ex vivo long-term expansion of human hematopoietic stem and progenitor cells as a tool for modeling vector integration sites and clonality.

Journal: Journal of translational medicine

Published: October 29, 2025

Therapeutic antibody delivery: vector tools to boost efficacy and affordability.

Therapeutic antibody delivery: vector tools to boost efficacy and affordability.

Journal: Frontiers in immunology

Published: September 27, 2025

Showing 1-12 of 319

Last Updated: 09/26/2026